Lineage Cell Therapeutics, Inc. (LCTX) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 5 买入.
分析师预估 每股收益(EPS)为 $-0.06 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.09 vs 预期 $-0.06 (不及预期 -59.5%). 2025: 实际 $-0.28 vs 预期 $-0.30 (超预期 +5.3%). 分析师准确度: 79%.
LCTX 分析师评级
Buy
基于过去3个月内 5 位分析师对 Lineage Cell Therapeutics, Inc. 的评级
EPS 预测 — LCTX
79%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.09
vs Est –$0.06
▼ 37.3% off
2025
Actual –$0.28
vs Est –$0.30
▲ 5.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — LCTX
77%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.009B
vs Est $0.008B
▲ 13.9% off
2025
Actual $0.015B
vs Est $0.010B
▲ 32.0% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
